MedTrace Logo

Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy

NCT01935115 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2017-09-13

No results posted yet for this study

Summary

To determine the effect of ketamine, compared to propofol, when used an an anesthetic agent for electroconvulsive therapy (ECT) in the treatment of major depressive disorder (MDD). We hypothesize that ketamine, compared to propofol, will improve the the symptoms of MDD when used as the anesthetic agent to facilitate ECT. Additionally, we hypothesize the dissociative and cardiovascular effects of ketamine will be minimal.

Conditions

Interventions

DRUG

Propofol

Propofol anesthesia for ECT

DRUG

Ketamine

Ketamine anesthesia for ECT

Sponsors & Collaborators

  • Saskatoon Health Region

    collaborator OTHER

  • Royal University Hospital Foundation

    collaborator OTHER

  • Schulman Research Award

    collaborator UNKNOWN

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Jonathan Gamble, MD · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01935115 on ClinicalTrials.gov